NL7304610A - - Google Patents

Info

Publication number
NL7304610A
NL7304610A NL7304610A NL7304610A NL7304610A NL 7304610 A NL7304610 A NL 7304610A NL 7304610 A NL7304610 A NL 7304610A NL 7304610 A NL7304610 A NL 7304610A NL 7304610 A NL7304610 A NL 7304610A
Authority
NL
Netherlands
Application number
NL7304610A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7304610A publication Critical patent/NL7304610A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
NL7304610A 1972-04-04 1973-04-03 NL7304610A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1528072A GB1437781A (en) 1972-04-04 1972-04-04 Pyridine derivatives having hypoglycaemic activity

Publications (1)

Publication Number Publication Date
NL7304610A true NL7304610A (xx) 1973-10-08

Family

ID=10056262

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7304610A NL7304610A (xx) 1972-04-04 1973-04-03

Country Status (20)

Country Link
JP (1) JPS49100091A (xx)
AR (1) AR208269A1 (xx)
AT (1) AT339301B (xx)
BE (1) BE797715A (xx)
BG (1) BG20352A3 (xx)
CA (1) CA999868A (xx)
CH (1) CH576961A5 (xx)
CS (1) CS183689B2 (xx)
DD (1) DD106834A5 (xx)
DE (1) DE2316881A1 (xx)
ES (1) ES413279A1 (xx)
FR (1) FR2182933B1 (xx)
GB (1) GB1437781A (xx)
HU (1) HU165731B (xx)
IE (1) IE37412B1 (xx)
IL (1) IL41825A (xx)
NL (1) NL7304610A (xx)
PL (1) PL96043B1 (xx)
RO (2) RO62274A (xx)
ZA (1) ZA731853B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409227A (en) 1979-08-09 1983-10-11 The Dow Chemical Co. 4-(((Heterocyclo)thio)methyl)benzoic acids, esters and amides and their pharmaceutical use
ES2077973T3 (es) * 1991-07-03 1995-12-01 Unilever Nv Rellenos de chocolate con aditivo anti-eflorescente.
ATE121271T1 (de) * 1991-07-03 1995-05-15 Unilever Nv Verbesserte schokolade-zusammensetzung.
US5453433A (en) * 1994-05-13 1995-09-26 Sterling Winthrop Inc. Thiadiazoles and antipicornaviral compositions
US6043247A (en) * 1996-04-19 2000-03-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
AU2381497A (en) * 1996-04-19 1997-11-12 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
EP1056714B1 (en) 1998-02-26 2004-08-11 Celltech Therapeutics Limited Phenylalanine derivatives as inhibitors of alpha4 integrins
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9812088D0 (en) 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
AU2001248553A1 (en) 2000-04-17 2001-10-30 Celltech R And D Limited Enamine derivatives as cell adhesion molecules
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6740654B2 (en) 2000-07-07 2004-05-25 Celltech R & D Limited Squaric acid derivatives
AU2001275724A1 (en) 2000-08-02 2002-02-13 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
US7101910B2 (en) * 2001-06-12 2006-09-05 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
GB0405033D0 (en) * 2004-03-05 2004-04-07 Karobio Ab Novel pharmaceutical compositions
TWI490214B (zh) * 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
EP3019034B1 (en) * 2013-07-01 2018-10-31 Givaudan SA Organic compounds
WO2016167153A1 (ja) * 2015-04-15 2016-10-20 長谷川香料株式会社 ピリジン誘導体またはその塩を有効成分とする香味変調剤
EP3440052B1 (en) * 2016-04-06 2023-10-25 University Of Oulu Compounds for use in the treatment of cancer

Also Published As

Publication number Publication date
IL41825A (en) 1977-03-31
FR2182933B1 (xx) 1976-05-14
AR208269A1 (es) 1976-12-20
ATA286773A (de) 1977-02-15
BE797715A (fr) 1973-10-03
IL41825A0 (en) 1973-05-31
CA999868A (en) 1976-11-16
CS183689B2 (en) 1978-07-31
DE2316881A1 (de) 1973-10-11
RO62274A (fr) 1977-12-15
AT339301B (de) 1977-10-10
ZA731853B (en) 1974-01-30
BG20352A3 (xx) 1975-11-05
JPS49100091A (xx) 1974-09-20
ES413279A1 (es) 1976-01-01
RO63069A (fr) 1978-08-15
IE37412L (en) 1973-10-04
HU165731B (xx) 1974-10-28
FR2182933A1 (xx) 1973-12-14
IE37412B1 (en) 1977-07-20
CH576961A5 (xx) 1976-06-30
PL96043B1 (pl) 1977-11-30
DD106834A5 (xx) 1974-07-05
GB1437781A (en) 1976-06-03

Similar Documents

Publication Publication Date Title
FR2182933B1 (xx)
JPS4944466A (xx)
JPS4965226A (xx)
JPS531619Y2 (xx)
JPS4895390A (xx)
JPS5213311B2 (xx)
JPS496009U (xx)
JPS4921757U (xx)
CH567918A5 (xx)
CH568795A5 (xx)
CH568313A5 (xx)
CH570655A5 (xx)
CH568238A5 (xx)
CH570770A5 (xx)
CH571344A5 (xx)
CH571650A5 (xx)
CH573474A5 (xx)
CH568002A5 (xx)
CH563195A5 (xx)
BE781579R (xx)
CH566172A5 (xx)
CH577642A5 (xx)
CH575026B5 (xx)
CH578036A5 (xx)
CH562132A5 (xx)

Legal Events

Date Code Title Description
BV The patent application has lapsed